Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 4 | 2024 | 1068 | 0.850 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 744 | 0.480 |
Why?
|
| Health Status Disparities | 1 | 2019 | 702 | 0.390 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 1679 | 0.340 |
Why?
|
| Immunity, Innate | 2 | 2024 | 168 | 0.340 |
Why?
|
| Chalcone | 1 | 2010 | 5 | 0.340 |
Why?
|
| Chalcones | 1 | 2010 | 15 | 0.330 |
Why?
|
| Neurites | 1 | 2010 | 40 | 0.330 |
Why?
|
| Cathepsins | 3 | 2004 | 10 | 0.270 |
Why?
|
| Liver | 2 | 2024 | 503 | 0.260 |
Why?
|
| Inflammation | 2 | 2024 | 729 | 0.250 |
Why?
|
| Enzyme Precursors | 4 | 2004 | 14 | 0.240 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1420 | 0.210 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 52 | 0.210 |
Why?
|
| Bodily Secretions | 1 | 2000 | 1 | 0.170 |
Why?
|
| Secretory Vesicles | 1 | 2000 | 21 | 0.170 |
Why?
|
| Basement Membrane | 1 | 2019 | 26 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 84 | 0.150 |
Why?
|
| Genetic Variation | 2 | 2019 | 429 | 0.150 |
Why?
|
| Silver | 1 | 2019 | 61 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 97 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2024 | 1066 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2024 | 990 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 129 | 0.130 |
Why?
|
| Lysosomes | 4 | 2004 | 88 | 0.130 |
Why?
|
| Male | 6 | 2024 | 22745 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 273 | 0.120 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 227 | 0.120 |
Why?
|
| Obesity | 1 | 2024 | 1129 | 0.120 |
Why?
|
| Receptors, Steroid | 1 | 2015 | 37 | 0.110 |
Why?
|
| Hepatocytes | 1 | 2015 | 79 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 979 | 0.110 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2013 | 3 | 0.100 |
Why?
|
| Humans | 10 | 2024 | 42113 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 29 | 0.100 |
Why?
|
| Ethanol | 1 | 2015 | 221 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 858 | 0.090 |
Why?
|
| Chlorofluorocarbons, Methane | 1 | 2010 | 3 | 0.080 |
Why?
|
| Butadienes | 1 | 2010 | 29 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 44 | 0.080 |
Why?
|
| PC12 Cells | 1 | 2010 | 93 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2E1 | 2 | 2024 | 24 | 0.080 |
Why?
|
| Nitriles | 1 | 2010 | 78 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 122 | 0.080 |
Why?
|
| Flavonoids | 1 | 2010 | 94 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2002 | 278 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 727 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 159 | 0.080 |
Why?
|
| United States | 1 | 2019 | 5068 | 0.070 |
Why?
|
| Animals | 6 | 2024 | 16694 | 0.070 |
Why?
|
| Cathepsin L | 3 | 2004 | 16 | 0.070 |
Why?
|
| Models, Biological | 1 | 2010 | 710 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 1416 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 2 | 2004 | 64 | 0.060 |
Why?
|
| Mice | 4 | 2024 | 6490 | 0.060 |
Why?
|
| Apoptosis | 2 | 2012 | 1541 | 0.060 |
Why?
|
| Female | 3 | 2024 | 23980 | 0.060 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2024 | 18 | 0.050 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 18 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2024 | 55 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 36 | 0.050 |
Why?
|
| Camptothecin | 1 | 2003 | 24 | 0.050 |
Why?
|
| Rats | 1 | 2010 | 3701 | 0.050 |
Why?
|
| Glioma | 1 | 2003 | 92 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 2598 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2004 | 534 | 0.040 |
Why?
|
| Proteins | 1 | 2024 | 383 | 0.040 |
Why?
|
| trans-Golgi Network | 1 | 2000 | 5 | 0.040 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2000 | 2 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 2000 | 30 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2000 | 28 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2000 | 13 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 79 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2024 | 548 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2003 | 355 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 108 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1265 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2000 | 400 | 0.040 |
Why?
|
| Cathepsin D | 1 | 1998 | 17 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2000 | 1617 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 2790 | 0.030 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2015 | 10 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2015 | 9 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2015 | 44 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 141 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 120 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2013 | 6 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 253 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 658 | 0.020 |
Why?
|
| Entropy | 1 | 2012 | 13 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 201 | 0.020 |
Why?
|
| Transfection | 2 | 2003 | 526 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 366 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 190 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 585 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1804 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 7958 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 96 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 297 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1001 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 11790 | 0.020 |
Why?
|
| Transport Vesicles | 1 | 2004 | 22 | 0.010 |
Why?
|
| Endosomes | 1 | 2004 | 34 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 3933 | 0.010 |
Why?
|
| Carmustine | 1 | 2003 | 1 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 62 | 0.010 |
Why?
|
| Carboplatin | 1 | 2003 | 20 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 295 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 189 | 0.010 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2002 | 6 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 173 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2002 | 4 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 61 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 42 | 0.010 |
Why?
|
| Microsomes | 1 | 2002 | 55 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 506 | 0.010 |
Why?
|
| ras Proteins | 1 | 2002 | 54 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 209 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 122 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 379 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2003 | 267 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 884 | 0.010 |
Why?
|
| Saposins | 1 | 1998 | 10 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1998 | 37 | 0.010 |
Why?
|
| Paclitaxel | 1 | 1998 | 64 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1845 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1998 | 127 | 0.010 |
Why?
|
| Binding Sites | 1 | 1998 | 670 | 0.010 |
Why?
|